SKXJF yields 4.53% · PFE yields 6.13%● Live data
📍 SKXJF pulled ahead of the other in Year 1
Combined, SKXJF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of SKXJF + PFE for your $10,000?
Sankyo Co., Ltd. manufactures and sells game machines and ball bearing supply systems in Japan. It operates through Pachinko Machines Business, Pachislot Machines Business, Ball Bearing Supply Systems Business, and Other Businesses segments. The Pachinko Machines Business segment produces and sells pachinko machines, machine gauges, as well as sells related parts. The Pachinko Machines Business segment produces and sells pachislot machines, and sells related parts. The Ball Bearing Supply Systems Business segment produces and sells pachinko and pachislot ball feeders, card system equipment, and parlor equipment and peripherals. The Other Businesses segment engages in real estate rental and sale of general molded parts. The company also offers mobile content services and operates a golf club. The company sells its products under the SANKYO and Bisty brands. Sankyo Co., Ltd. was incorporated in 1960 and is headquartered in Tokyo, Japan.
Full SKXJF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.